3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Neuroendocrine Tumors
7
Neoplasms
6
Colorectal Neoplasms
5
Carcinoma, Hepatocellular
5
Carcinoid Tumor
5
Stomach Neoplasms
4
Esophageal Neoplasms
4
Acromegaly
4
Weight Loss
3
Rectal Neoplasms
3
Pancreatic Neoplasms
3
Diarrhea
3
Carcinoma
3
Breast Neoplasms
3
Vipoma
2
Thymoma
2
Somatostatinoma
2
Pituitary Neoplasms
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Malnutrition
2
Intestinal Obstruction
2
Insulinoma
2
Glucagonoma
2
Colonic Neoplasms
2
Carcinoma, Islet Cell
2
Adenoma, Islet Cell
2
Zollinger-Ellison Syndrome
1
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Interventions
Hydroxyurea
4
aldesleukin
3
Magnetic Resonance Spectroscopy
3
Imatinib Mesylate
3
Everolimus
3
Temozolomide
2
Surveys and Questionnaires
2
Surgical Procedures, Operative
2
Radiotherapy, Intensity-Modulated
2
Radiotherapy, Conformal
2
Psychiatric Rehabilitation
2
Proton Therapy
2
Paclitaxel
2
Laser Speckle Contrast Imaging
2
Filgrastim
2
Donepezil
2
Cyclophosphamide
2
Carmustine
2
Bortezomib
2
Bevacizumab
2
Aminolevulinic Acid
2
90Y-octreotide, DOTA-Tyr(3)-
2
vistusertib
1
vatalanib
1
trametinib
1
tozuleristide
1
temsirolimus
1
sonidegib
1
sargramostim
1
ribociclib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Meningioma
×
Octreotide
×
Clear all
NCT02333565
2023-05-25
CEVOREM
Assistance Publique Hopitaux De Marseille
Phase 2
Completed
20 enrolled